Could acute COVID-19 infection ignite thrombotic risk?

Abstract

With the growing body of evidence of the ischaemic and thrombotic risks associated with recent COVID-19 infection, this expert commentary reviews the data on the cardiovascular risk implications of COVID-19 and considers potential management approaches for these patients. The authors' opinions were gauged against a global healthcare professional survey to measure current levels of agreement, lending support to their validity. While the need for ongoing research to improve the understanding of this disease is appreciated, the authors recognise that there is the potential to transform management approaches to reduce the health impact of COVID-19 infection among high-risk patients, especially those with established cardiovascular disease.

Rights

This work is open access and is licensed under CC-BY-NC 4.0. Users may copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly. https://creativecommons.org/licenses/by-nc/4.0/

Cite as

Downloadable citations

Identifiers

DOI

https://doi.org/10.15420/ecr.2024.62

Repository URI

https://eprints.gla.ac.uk/357583/